Metabolon’s focus on metabolic oncology diagnostic products is to provide therapy guidance in areas of significant unmet medical need. The tests Metabolon develops are designed to provide information that will change clinical practice by allowing physicians to choose the best course of therapy for each patient. In some cases, unnecessary surgical procedures, expensive imaging tests, and drug treatments can be avoided. Developing tests based on the unique metabolic physiology of individual patients and their tumors to guide therapy truly advances the frontiers of personalized medicine.